J M Smucker Co vs 10X Genomics Inc — how do they compare? J M Smucker Co trades at $112.69 (market cap $11.97B), while 10X Genomics Inc trades at $46.82 (market cap $5.48B). The key difference: J M Smucker Co is far larger — about 2.2× 10X Genomics Inc's market cap, and J M Smucker Co pays a 3.93% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| SJM | TXG | |
|---|---|---|
Market Cap | $11.97B | $5.48B |
Sector | Consumer Staples | Health |
52-Week High | $117.05 | $45.80 |
52-Week Low | $89.53 | $11.34 |
Enterprise Value | $19.00B | $5.02B |
Dividend Yield | 3.93% | — |
Trailing returns across standard periods
Latest headlines on both assets
J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →